E
Ultragenyx Pharmaceutical Inc. RARE
$39.34 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -8.28% 16.37% 17.66% -4.09% 18.86%
Total Depreciation and Amortization 10.48% 21.78% 65.30% 68.93% 65.79%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 24.14% -15.25% -5.56% -32.57% -48.79%
Change in Net Operating Assets 71.01% 1,001.00% 128.50% -46.02% -39.11%
Cash from Operations 5.25% 43.16% 33.74% -21.59% 7.13%
Capital Expenditure 59.13% 56.24% 85.59% 87.17% 94.07%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 198.08% -502.83% -44.80% -28.38% 27.30%
Cash from Investing 196.00% -528.50% -39.08% -15.16% 37.64%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -99.04% -83.46% 1,090.62% -- 16,422.24%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -91.64% 91.97% 100.00%
Cash from Financing -99.04% -55.72% 1,065.78% 91.97% 17,466.95%
Foreign Exchange rate Adjustments -324.21% 278.07% -376.47% -421.80% -18.42%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -82.99% -1,035.71% 2,179.24% -110.59% 154.42%
Weiss Ratings